天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2015年
6期
642-645
,共4页
常江%王颖%柳利%王满仓
常江%王穎%柳利%王滿倉
상강%왕영%류리%왕만창
胰岛素样生长因子2信使RNA结合蛋白3%结肠癌%DNA甲基化%分化%免疫组织化学%甲基化特异性PCR
胰島素樣生長因子2信使RNA結閤蛋白3%結腸癌%DNA甲基化%分化%免疫組織化學%甲基化特異性PCR
이도소양생장인자2신사RNA결합단백3%결장암%DNA갑기화%분화%면역조직화학%갑기화특이성PCR
IGF2BP3%colonic neoplasms%DNA methylation%differentiation%immunohistochemistry%methylation-specific PCR
目的:探讨IGF2BP3低甲基化与结肠癌组织分化之间的关系。方法收集2011年3月—8月在我院就诊的结肠癌组织标本41例,其中高分化腺癌19例,中分化腺癌12例,低分化腺癌10例,同时收集结肠炎标本12例作为对照。免疫组化和Western blot检测标本IGF2BP3表达。改进ELISA法检测标本DNA总甲基化水平,甲基化特异性PCR(MS-PCR)检测IGF2BP3甲基化水平。结果免疫组化和Western blot结果示结肠癌组织IGF2BP3表达高于结肠炎组织(P<0.05),低分化结肠癌组IGF2BP3表达水平最高,中、高分化程度间表达无明显差异。结肠癌组基因总甲基化水平和IGF2BP3甲基化水低于结肠炎组(均P<0.05),且随着结肠组织分化程度降低,IGF2BP3甲基化水平依次降低(P<0.05)。结论 IGF2BP3甲基化水平与结肠癌分化程度密切相关,在调控结肠癌组织IGF2BP3表达中具有重要价值。
目的:探討IGF2BP3低甲基化與結腸癌組織分化之間的關繫。方法收集2011年3月—8月在我院就診的結腸癌組織標本41例,其中高分化腺癌19例,中分化腺癌12例,低分化腺癌10例,同時收集結腸炎標本12例作為對照。免疫組化和Western blot檢測標本IGF2BP3錶達。改進ELISA法檢測標本DNA總甲基化水平,甲基化特異性PCR(MS-PCR)檢測IGF2BP3甲基化水平。結果免疫組化和Western blot結果示結腸癌組織IGF2BP3錶達高于結腸炎組織(P<0.05),低分化結腸癌組IGF2BP3錶達水平最高,中、高分化程度間錶達無明顯差異。結腸癌組基因總甲基化水平和IGF2BP3甲基化水低于結腸炎組(均P<0.05),且隨著結腸組織分化程度降低,IGF2BP3甲基化水平依次降低(P<0.05)。結論 IGF2BP3甲基化水平與結腸癌分化程度密切相關,在調控結腸癌組織IGF2BP3錶達中具有重要價值。
목적:탐토IGF2BP3저갑기화여결장암조직분화지간적관계。방법수집2011년3월—8월재아원취진적결장암조직표본41례,기중고분화선암19례,중분화선암12례,저분화선암10례,동시수집결장염표본12례작위대조。면역조화화Western blot검측표본IGF2BP3표체。개진ELISA법검측표본DNA총갑기화수평,갑기화특이성PCR(MS-PCR)검측IGF2BP3갑기화수평。결과면역조화화Western blot결과시결장암조직IGF2BP3표체고우결장염조직(P<0.05),저분화결장암조IGF2BP3표체수평최고,중、고분화정도간표체무명현차이。결장암조기인총갑기화수평화IGF2BP3갑기화수저우결장염조(균P<0.05),차수착결장조직분화정도강저,IGF2BP3갑기화수평의차강저(P<0.05)。결론 IGF2BP3갑기화수평여결장암분화정도밀절상관,재조공결장암조직IGF2BP3표체중구유중요개치。
Objective To investigate the relationship between IGF2BP3 hypomethylation with colon tumor differentia?tion. Methods Tissue samples from 41 colorectal cancer were collected from March 2011 to August 2011 in our hospital, among which 19 cases were well-differentiated adenocarcinoma, 12 cases were of moderately differentiated adenocarcinoma and 10 cases were of poorly differentiated adenocarcinoma. Meanwhile biopsy samples from 12 cases of colonic colitis were collected as a control. The expression of IGF2BP3 was assessed by immunohistochemistry and Western blot. An innovate of ELISA technique was used to examine global methylation levels while IGF2BP3 methylation level was tested by methylation specific PCR technique. Results The expressions of IGFBP3 are higher in all colon cancer groups than that in colitis (P<0.05). The expression of IGFBP3 in poorly differentiated adenocarcinoma is higher than that in all the other groups, but there is no significant difference between its expressions in the well differentiated group and in the moderately differentiated adeno?carcinoma group. The global DNA level and IGFBP3 methylation level of every colon cancer group is lower than those in coli?tis (P<0.05). Also, a tendency of decreasing global DNA and IGFBP3 methylation status was observed comparing well differ?entiated towards poorly differentiated carcinomas (P<0.05). Conclusion IGF2BP3 expression in colorectal cancer is asso?ciated with differentiation of colon cancer tissue. A lower global and IGF2BP3 DNA methylation suggest a worse differentia?tion of colon cancer. DNA hypomethylation may therefore play a regulatory role in the expression of IGF2BP3 in colon cancer tissue.